#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	2914	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2498	340.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1797	1797	C	433	C	361	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4558	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4004	341.1	0	.	n	.	0	T695C	SNP	695	695	T	1235	1235	C	360	C,A	297,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4558	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4004	341.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1877	1877	A	426	A	365	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4558	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4004	341.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2511	2511	C	392	C,A,T	325,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4558	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4004	341.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3137	3137	T	404	T,C	266,69	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4558	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4004	341.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2585	2585	A	422	A,G	359,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	488	folP	852	852	100.0	folP.l15.c4.ctg.1	2042	71.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1275	1277	AGC	125;125;126	A;G;C	100;104;104	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1044	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3663	85.2	1	SNP	p	S91F	0	.	.	271	273	TCC	671	673	TCC	106;107;107	T,C;C;C	87,1;86;86	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1044	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3663	85.2	1	SNP	p	D95G	0	.	.	283	285	GAC	683	685	GAC	107;107;107	G;A;C	88;88;88	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1044	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3663	85.2	1	SNP	p	D95N	0	.	.	283	285	GAC	683	685	GAC	107;107;107	G;A;C	88;88;88	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	390	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1730	67.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	633	635	ACC	102;104;104	A;C;C	92;92;94	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	390	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1730	67.4	0	.	p	.	0	R44H	NONSYN	130	132	CGC	648	650	CAC	105;105;106	C;A;C	90;93;94	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	390	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1730	67.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	831	833	CAC	117;117;118	C;A;C	95;97;101	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	390	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1730	67.4	1	SNP	p	G45D	0	.	.	133	135	GGC	651	653	GGC	106;107;108	G;G;C	92;94;95	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	270	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1311	61.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3360	89.8	1	SNP	p	D86N	0	.	.	256	258	GAC	766	768	GAC	107;108;107	G;A;C	93;88;89	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3360	89.8	1	SNP	p	S87W	0	.	.	259	261	AGT	769	771	AGT	106;106;106	A;G;T	87;87;88	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3360	89.8	1	SNP	p	S87R	0	.	.	259	261	AGT	769	771	AGT	106;106;106	A;G;T	87;87;88	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3360	89.8	1	SNP	p	S87I	0	.	.	259	261	AGT	769	771	AGT	106;106;106	A;G;T	87;87;88	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1008	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3360	89.8	1	SNP	p	S88P	0	.	.	262	264	TCC	772	774	TCC	105;106;106	T;C;C	90;92;93	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	892	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3181	84.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1800	1802	GGC	113;112;112	G;G;C	89;87;88	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1449	1451	GCA	96;96;96	G;C;A	88;83;86	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1452	1454	ATC	96;97;96	A;T;C	86;83;85	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1464	1466	GTG	95;95;96	G;T;G	85;81;84	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1464	1466	GTG	95;95;96	G;T;G	85;81;84	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1968	1970	ACC	95;95;95	A;C;C	78;78;81	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2022	2024	GCG	92;92;93	G;C,G;G,C	76;67,1;72,2	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2022	2024	GCG	92;92;93	G;C,G;G,C	76;67,1;72,2	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2145	2147	GGC	102;103;102	G,C;G;C	78,1;84;85	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2154	2156	GGC	104;103;104	G;G;C	84;78;84	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	762	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2817	81.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2172	2174	CCG	104;110;112	C;C;G	80;89;89	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	954	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3610	79.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	572	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2180	78.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	778	778	C	98	C,G	79,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	0	.	p	.	0	G46D	NONSYN	136	138	GGC	659	661	GAC	102;100;99	G;A;C	90;88;88	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	0	.	p	.	0	E48G	NONSYN	142	144	GAA	665	667	GGA	98;98;99	G,T;G;A	89,1;89;90	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	0	.	p	.	0	F135L	NONSYN	403	405	TTT	926	928	CTT	112;113;113	C;T;T	88;89;91	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	0	.	p	.	0	R143G	NONSYN	427	429	AGA	950	952	GGA	118;118;118	G;G;A	98;94;99	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	0	.	p	.	0	D171G	NONSYN	511	513	GAT	1034	1036	GGT	101;102;102	G;G;T	90;88;92	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1088	1090	AGC	92;91;91	A,G;G;C,T	82,1;82;81,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1154	1154	T	104	T	89	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	1	SNP	p	G120K	0	.	.	358	360	GGT	881	883	GGT	110;110;110	G;G;T	90;86;86	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	1	SNP	p	A121D	0	.	.	361	363	GCC	884	886	GCC	110;110;110	G;C;C	86;87;83	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	522	porB1b	1035	1035	95.73	porB1b.l15.c4.ctg.1	1953	79.3	1	SNP	p	A121N	0	.	.	361	363	GCC	884	886	GCC	110;110;110	G;C;C	86;87;83	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1908	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5431	105.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2243	2245	AAT	113;112;112	A;A;T	99;103;102	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	296	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1343	65.4	1	SNP	p	V57M	1	.	.	169	171	ATG	660	662	ATG	116;115;115	A;T;G	93;93;92	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
